Metropolitan Life Insurance Company (MetLife)’s Origin Materials ORGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-210
Closed -$8.06K 2376
2023
Q3
$8.06K Buy
210
+27
+15% +$2.12K ﹤0.01% 2309
2023
Q2
$23.3K Hold
183
﹤0.01% 1848
2023
Q1
$23.4K Sell
183
-44
-19% -$6.5K ﹤0.01% 1802
2022
Q4
$31.4K Hold
227
﹤0.01% 1763
2022
Q3
$35.1K Hold
227
﹤0.01% 1699
2022
Q2
$34.8K Buy
+227
New +$43.3K ﹤0.01% 1724

Other funds holding ORGN

Metropolitan Life Insurance Company (MetLife)'s ORGN Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Origin Materials (ORGN) in Q4 2023, closing a stake of 210 shares — an estimated $8.06K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ORGN in Q2 2022 and held it in 6 quarters. The position peaked at $35.1K in Q3 2022. 99 funds tracked by Wall St. Rank hold ORGN as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Origin Materials position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 210 Origin Materials shares in Q4 2023, an estimated $8.06K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Origin Materials in Q2 2022 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Origin Materials position peaked at $35.1K in Q3 2022.
  • 99 funds tracked by Wall St. Rank held Origin Materials as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.